During the past decade, River Birch Research Alliance, LLC conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 26 clinical trials were completed, i.e. on average, 152.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 16 clinical trials were completed. i.e. 1600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "River Birch Research Alliance, LLC" #1 sponsor was "Pfizer" with 8 trials, followed by "Allergan" with 6 trials sponsored, "AstraZeneca" with 4 trials sponsored, "BioDelivery Sciences International" with 3 trials sponsored and "Gan and Lee Pharmaceuticals, USA" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "River Birch Research Alliance, LLC" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 2 trials as a collaborator, "Camurus AB" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "River Birch Research Alliance, LLC" are "Low Back Pain" (6 trials), "Gastroparesis" (5 trials), "Type 2 Diabetes" (5 trials), "Diabetes Mellitus" (4 trials) and "Osteoarthritis" (4 trials). Many other conditions were trialed in "River Birch Research Alliance, LLC" in a lesser frequency.

Most popular intervention types in "River Birch Research Alliance, LLC" are "Drug" (28 trials), "Biological" (8 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Relamorelin" (4 trials), "Buprenorphine" (2 trials), "Dapagliflozin" (2 trials) and "Gan & Lee Insulin Glargine Injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "River Birch Research Alliance, LLC" are 35 trials for "All" genders.

Currently, there are NaN active trials in "River Birch Research Alliance, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in River Birch Research Alliance, LLC, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in River Birch Research Alliance, LLC, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".